ImmunoPrecise AntibodiesIPA 
$0.6613.99%24h
13.99%24h
Global rank30690
Market cap$17.37M
Change 7d1.54%
YTD Performance-59.51%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of ImmunoPrecise Antibodies (IPA)
As of November 2024, ImmunoPrecise Antibodies has a market cap of $17.37M. This makes ImmunoPrecise Antibodies the world's 30690th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of ImmunoPrecise Antibodies from 2002 to 2024
-
Value:-
Market cap history of ImmunoPrecise Antibodies from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $51.05M | 13.45% |
| 2023 | $45.00M | -67.18% |
| 2022 | $137.10M | -2.80% |
| 2021 | $141.05M | -64.15% |
| 2020 | $393.41M | 579.55% |
| 2019 | $57.89M | -13.89% |
| 2018 | $67.24M | 9.42% |
| 2017 | $61.45M | 46600.00% |
| 2016 | $131.58K | -66.67% |
| 2015 | $394.73K | -95.24% |
| 2014 | $8.29M | 250.00% |
| 2013 | $2.37M | -70.00% |
| 2012 | $7.89M | -71.83% |
| 2011 | $28.03M | -74.64% |
| 2010 | $110.52M | -41.67% |
| 2009 | $189.47M | 380.00% |
| 2008 | $39.47M | -90.00% |
| 2007 | $394.73M | 19.05% |
| 2006 | $331.57M | -44.00% |
| 2005 | $592.09M | -25.00% |
| 2004 | $789.46M | -29.82% |
| 2003 | $1.12B | 612.50% |
| 2002 | $157.89M | - |
IPA Market Cap Today is $17.37M 13.99% - 21 Nov 2024
View largest stocks by market cap 
